Thursday, August 11, 2022
name of Prensa Latina
Bandera inglesa
English Edition
name of Prensa Latina

NEWS

NEWS

Russia starts clinical trials with intranasal Covid-19 vaccine

Rusia, Covid-19, vacuna, Sputnik V, nasal, ensayos

Russia starts clinical trials with intranasal Covid-19 vaccine

Moscow, Nov 27 (Prensa Latina) The Gamaleya Research Institute of Epidemiology and Microbiology started the clinical trials in Russia of a Covid-19 vaccine in the format of nasal spray, Director Alexander Gintsburg announced on Saturday.
Share on facebook
Share on twitter
Share on whatsapp
Share on telegram
Share on email

This scientist told Rossiya 1 channel that, with the ongoing research, the trials have started to test that intranasal form of the Sputnik V vaccine from the Gamaleya Institute.

He recalled that, a few days ago, President Vladimir Putin got vaccinated again against the SARS-CoV-2 coronavirus using this form and said he would be the first to test it.

Ginstburg said that the new vaccine is administered with an ordinary syringe, with a special mouthpiece in the tip instead of a needle, which has a filter with tiny holes.

In October, Russia’s Ministry of Health authorized the beginning of the second phase of the clinical trials of this candidate, which, according to Gintsburg, is another barrier against this infection, but will not replace the need of inoculating the vaccine.

The expert also said that the children who have been immunized so far as part of the trials of the nasal vaccine did not have adverse effects after vaccination.

Gamaleya Center Deputy Director Denis Logunov said the vaccine is painless and has minimal side effects.

mh/aph/mem/mml

RELATED
ÚLTIMO MINUTO
name of Prensa Latina

| Text SMS to 8100 with content PL
Receive 4 mesages x 25 cup

© 2016-2021 Prensa Latina
Latin American News Agency

Radio – Publications  – Videos – News by the minute.
All Rigts Reserved.

St. E No 454 , Vedado,  Habana, Cuba.
Phones: (+53) 7 838 3496, (+53) 7 838 3497, (+53) 7 838 3498, (+53) 7 838 3499
Prensa Latina © 2021 .

Web Site developed by IT Division  Prensa Latina.